Online citations, reference lists, and bibliographies.

Pregnancy Vaccination With Gold Glyco-Nanoparticles Carrying Listeria Monocytogenes Peptides Protects Against Listeriosis And Brain- And Cutaneous-Associated Morbidities

Ricardo Calderón-Gonzalez, H. Terán-Navarro, Elisabet Frande-Cabanes, Eva Ferrández-Fernández, J. Freire, Soledad Penadés, Marco Marradi, I. García, Javier Gomez-Román, S. Yañez-Diaz, Carmen Álvarez-Domínguez
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Listeriosis is a fatal infection for fetuses and newborns with two clinical main morbidities in the neonatal period, meningitis and diffused cutaneous lesions. In this study, we vaccinated pregnant females with two gold glyconanoparticles (GNP) loaded with two peptides, listeriolysin peptide 91–99 (LLO91–99) or glyceraldehyde-3-phosphate dehydrogenase 1–22 peptide (GAPDH1–22). Neonates born to vaccinated mothers were free of bacteria and healthy, while non-vaccinated mice presented clear brain affections and cutaneous diminishment of melanocytes. Therefore, these nanoparticle vaccines are effective measures to offer pregnant mothers at high risk of listeriosis interesting therapies that cross the placenta.
This paper references
10.1016/j.vaccine.2012.05.033
Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
Elena Jiménez-Ruiz (2012)
10.1111/j.1574-695X.2008.00404.x
Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion.
D. Drevets (2008)
10.1016/j.pneurobio.2015.05.003
Alternatively activated microglia and macrophages in the central nervous system
R. Franco (2015)
10.3201/eid2012.140993
Two Outbreaks of Listeria monocytogenes Infection, Northern Spain
E. Pereztrallero (2014)
C. Cellular vaccines in listeriosis: Role of the Listeria antigen GAPDH. Front. Cell
R Calderon-Gonzalez
10.1111/J.1471-4159.2006.04328.X
Tubulin cofactor B plays a role in the neuronal growth cone.
M. López-Fanarraga (2007)
10.1166/JBN.2014.1991
Nanoparticle based tailoring of adjuvant function: the role in vaccine development.
C. K. Prashant (2014)
10.1128/IAI.01110-09
Toll-Like Receptor Stimulation Enhances Phagocytosis and Intracellular Killing of Nonencapsulated and Encapsulated Streptococcus pneumoniae by Murine Microglia
S. Ribes (2009)
Studies with Listeria monocytogenes
E. R. Unanue (2012)
infected with Listeria monocytogenes
O. Disson (2014)
10.1086/605637
Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study.
N. Fernández-Sabé (2009)
10.1002/chem.200900923
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
O. Martínez-Ávila (2009)
In vitro and in vivo models to study human listeriosis: Mind the gap. Microbes Infect
O Disson (2013)
10.1021/bc200606s
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Raymond P. Briñas (2012)
Vaccine
L Zhao (2014)
10.2807/1560-7917.ES2015.20.17.21104
Cheese-related listeriosis outbreak, Portugal, March 2009 to February 2012.
R. Magalhães (2015)
10.1016/B978-0-12-394590-7.00009-9
Studies with Listeria monocytogenes lead the way.
Emil R. Unanue (2012)
Cheese-related listeriosis outbreak
R. Magalhaes (2009)
10.3389/fcimb.2013.00013
Vaccine delivery using nanoparticles
A. Gregory (2013)
10.1002/glia.22602
Dissociation of Innate Immune Responses in Microglia Infected with Listeria monocytogenes
E. Frande-Cabanes (2014)
10.1111/j.1469-0691.2009.03109.x
Listeriosis: a resurgent foodborne infection.
F. Allerberger (2010)
10.1080/21645515.2015.1063756
Novel nanoparticle vaccines for Listeriosis
Ricardo Calderon-Gonzalez (2015)
10.1016/j.jim.2015.05.009
Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines
R. Calderon-Gonzalez (2015)
10.1038/NRI3517
Applications of nanotechnology for immunology
Douglas M. Smith (2013)
Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience.
J. Peña-Sagredo (2008)
10.1016/S0171-2985(99)80058-8
Immune reactions to Listeria monocytogenes in the brain.
D. Schlüter (1999)
10.1016/J.BBAGEN.2005.12.001
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science.
J. M. de la Fuente (2006)
10.1016/J.PEDIATRNEUROL.2005.06.003
TNF-α and IL-6 in the Diagnosis of Bacterial and Aseptic Meningitis in Children
Adriana de Oliveira Mukai (2006)
10.1038/cmi.2014.84
Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8+ T cells during pregnancy
Dayna R. Clark (2014)
10.1097/00005792-200207000-00002
Listeriosis During Pregnancy: A Case Series and Review of 222 Cases
M. Paliou (2002)
10.1002/CHIN.201332277
Glyconanoparticles as Multifunctional and Multimodal Carbohydrate Systems
Marco Marradi (2013)
Supplementary Materials: The following are available online at www.mdpi
10.1021/ja4046857
‘Multicopy Multivalent’ Glycopolymer-Stabilized Gold Nanoparticles as Potential Synthetic Cancer Vaccines
A. L. Parry (2013)
10.1038/pr.2012.2
Infection of pregnant mice with Listeria monocytogenes induces fetal bradycardia
J. Hardy (2012)
10.1016/j.micinf.2013.09.012
In vitro and in vivo models to study human listeriosis: mind the gap.
Olivier Disson (2013)
10.1021/acs.chemrev.5b00109
Synthetic Nanoparticles for Vaccines and Immunotherapy.
D. Irvine (2015)
10.1155/2015/191409
Molecular Epidemiology of Invasive Listeriosis due to Listeria monocytogenes in a Spanish Hospital over a Nine-Year Study Period, 2006–2014
Jaime Ariza-Miguel (2015)
10.1016/j.vaccine.2015.01.062
A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
Estela Rodríguez-Del Río (2015)
Conflicts of Interest: The authors declare that they have no conflicts of interest with the contents of this article
10.1134/S1995078010110029
Adjuvant properties of gold nanoparticles
L. Dykman (2010)
10.4172/2157-7560.1000266
A Dendritic Cell-Targeted Vaccine Loaded with Glyceraldehyde-3-Phosphate Dehydrogenase Peptides Proposed for Individuals at High Risk of Listeriosis
R. Calderon-Gonzalez (2012)
10.3389/fcimb.2014.00022
Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH
R. Calderon-Gonzalez (2014)
10.1016/j.ymeth.2013.04.014
Nanovaccines and their mode of action.
Mehfuz Zaman (2013)
10.1016/j.vaccine.2013.11.069
Nanoparticle vaccines.
L. Zhao (2014)
Novel nanoparticles vaccines Infection of pregnant mice with Listeria monocytogenes induces fetal bradicardia
R Calderon-Gonzalez (2012)
10.2217/nnm.11.151
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
D. Safari (2012)
10.1128/JCM.01974-13
Cutaneous Listeriosis
Casey E. Godshall (2013)



This paper is referenced by
10.1098/rsfs.2019.0046
Public health impact of foodborne exposure to naturally occurring virulence-attenuated Listeria monocytogenes: inference from mouse and mathematical models
Alison E Stout (2019)
10.18632/oncotarget.19405
GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination.
Ricardo Calderon-Gonzalez (2017)
10.1039/c6sc03631g
Immunological properties of gold nanoparticles
L. Dykman (2017)
10.1080/14760584.2020.1758070
Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases
L. Dykman (2020)
10.2147/IJN.S226186
Subcellular Performance of Nanoparticles in Cancer Therapy
C. Liu (2020)
10.1016/j.sjbs.2018.09.012
Size and time-dependent induction of proinflammatory cytokines expression in brains of mice treated with gold nanoparticles
Haseeb Ahmad Khan (2019)
10.3390/molecules22050857
Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines †
S. A. C. Carabineiro (2017)
10.1080/2162402X.2018.1541534
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
Hector Terán-Navarro (2019)
10.3389/fimmu.2016.00541
Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain
R. Calderon-Gonzalez (2016)
10.1039/c7nr02494k
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.
R. Calderon-Gonzalez (2017)
10.1021/acs.bioconjchem.7b00692
Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.
Pavimol Angsantikul (2018)
10.1080/14760584.2020.1758070
Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases
L. Dykman (2020)
Semantic Scholar Logo Some data provided by SemanticScholar